Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ribonucleic acid
- Development stage
- Unknown
- Lead developer
- Labo'Life
- Modality
- RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Sublingual
01
Overview
Ribonucleic acid k30 is a homeopathic preparation of ribonucleic acid (RNA) diluted to the 30th Korsakovian (30K) level. Developed by Labo'Life, it is a key component of micro-immunotherapy, a therapeutic system that uses low doses of immune-mediating substances to modulate the body's immune response. Specifically, ribonucleic acid k30 is used within complex formulations like 2LEBV, which is indicated for the treatment and management of Epstein-Barr virus (EBV) infections. The rationale behind its use is to provide regulatory signals to the immune system, potentially helping to control viral replication and restore immune homeostasis in patients with chronic or reactive EBV. It is typically formulated as sublingual globules consisting of a lactose-saccharose core impregnated with the diluted RNA.
- Other names
- ribonucleic acid k30RNA 30KRNA30KRNA-30KRibonucleic acid 30K
Beyond the preview
Go deeper on ribonucleic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ribonucleic acid.